Literature DB >> 2157831

Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183).

P Lind1, W Langsteger, P Költringer, H P Dimai, R Passl, O Eber.   

Abstract

Antigranulocyte immunoscintigraphy with a technetium-99m- (99mTc) labeled monoclonal antigranulocyte antibody (MAb BW 250/183) was performed in 34 in-patients of the departments of accident surgery and internal medicine in order to prove or exclude inflammatory processes. After labeling with 99mTc, 555 MBq, 99mTc-MAb (0.5 mg antibody) were slowly injected intravenously over a period of 5 min. A whole-body scan was done 4-6 hr postinjection, and planar or SPECT images were performed 6, 18, and 24 hr postinjection. Leukocyte immunoscintigraphy proved inflammatory suppurating processes in 20 cases (true-positive) and excluded them in 11 cases (true-negative). The findings were false-positive in two patients (hematoma without signs of infection, pseudoarthrosis) and false-negative in one patient (encapsulated lung abscess with pleural fibrosis). Anti-idiotypic human anti-mouse antibodies (HAMA) were found only in one out of 20 patients. According to our experiences, immunoscintigraphy with 99mTc-MAb BW 250/183 has a sensitivity of 95%, and is, therefore, well suited for the identification of leukocytic inflammations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157831

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  White blood cell scintigraphy with monoclonal antibodies in the study of the infected endoprosthesis.

Authors:  J Sciuk; C Puskás; B Greitemann; O Schober
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Radiopharmaceuticals: state of the art.

Authors:  A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?

Authors:  J F Chatal; P Peltier; M Bardiès; A Chétanneau; P Thedrez; A Faivre-Chauvet; J F Gestin
Journal:  Eur J Nucl Med       Date:  1992

4.  Use of immunoscintigraphy in the diagnosis of fever of unknown origin.

Authors:  W Becker; U Dölkemeyer; M Gramatzki; M U Schneider; J Scheele; F Wolf
Journal:  Eur J Nucl Med       Date:  1993-11

5.  Localising the cause of an undiagnosed fever.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1996-03

6.  Failure of labelling of anti-granulocyte antibody.

Authors:  C Decristoforo; F Chen; A Stöger; G Riccabona
Journal:  Eur J Nucl Med       Date:  1993-06

Review 7.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

8.  Immunoscintigraphy with antigranulocyte monoclonal antibodies for the diagnosis of septic loosening of hip prostheses.

Authors:  A Boubaker; A B Delaloye; C H Blanc; M Dutoit; P F Leyvraz; B Delaloye
Journal:  Eur J Nucl Med       Date:  1995-02

9.  Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labelled leucocyte scintigraphy in inflammatory bowel disease.

Authors:  I Segarra; M Roca; C Baliellas; L Vilar; Y Ricart; J Mora; R Puchal; J Martin-Comin
Journal:  Eur J Nucl Med       Date:  1991

Review 10.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.